Recognised by the Government of Maharashtra for Patented Innovation in Breast Cancer Treatment
Shashvi Remedies, a pioneer in healthcare innovation, has received a grant of Rs 10 lakhs for international patents from the Maharashtra State Innovation Society (MSINS) under the Government of Maharashtra’s Skill Development and Entrepreneurship Department (SDED). This acknowledgement is the demonstration of Shashvi Remedies’ persistent endeavour to identify PHARMA solutions for Critical Cancer disease that contributes to making a difference.
Shashvi Remedies’ patented innovation offers new hope by targeting and eliminating cancerous cells while preserving healthy tissue, representing a major step forward in patient-centred treatment options.
Shashvi’s patented breast cancer treatment is a highly valuable asset, with both Indian and global pharmaceutical companies recognising its potential.
A recent example of this trend is the acquisition of a US-based R&D firm by a leading Indian pharmaceutical company, securing a derma-oncology product for approximately $355 million—demonstrating the industry’s keen interest in breakthrough, early-stage oncology solutions.
Sonal Bansal, Founder, Shashvi Remedies, emphasising the importance of this recognition said, “We are honoured to receive this grant from MSINS, this has validated our attempt to turn scientific breakthrough into real-world impact. Setting a new benchmark from day one, our latest breast cancer innovation, makes breast cancer preventable and treatment more accessible and less daunting for patients. As India advances towards becoming a global powerhouse in healthcare, Shashvi Remedies stands at the forefront in driving innovation into impact for a healthier tomorrow.”
